Changes in surgery rates among hospitalized patients with inflammatory bowel disease in Japan from 2015 to 2019: A nationwide administrative database analysis.

Published in: Journal of gastroenterology and hepatology (2023)

In Japan, from 2015 to 2019, the use of biologics or JAKi increased for UC and slightly decreased for CD, while the number of surgeries decreased in both. Our findings suggest that more widespread use of biologics or JAKi therapy could reduce surgeries in patients with IBD.

Keyphrases

patients with inflammatory bowel disease
minimally invasive
coronary artery bypass
emergency department
mesenchymal stem cells
bone marrow
nk cells
percutaneous coronary intervention
drug induced